NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center
While advances in immunotherapy have dramatically improved cancer survival, unleashing the immune system can lead to a host of adverse reactions. How can patients pay less of a price?
Johns Hopkins cancer researcher Elizabeth Jaffee, who co-led the Cancer Moonshot Blue Ribbon Panel in 2016, discusses how far cancer research has come in the past five years and where it's headed in the next few decades